Aspirin, once the painkiller of choice, continues to impress scientists with its range of health benefits. Cancer prevention ...

Market.us, a leading provider of comprehensive market research, has published a detailed report on the Electronic Aspirin Market, offering valuable insights into this emerging sector of the healthcare ...

I don’t know how to weigh the risk/benefit ratio of aspirin therapy, considering these two factors. Can you help?

Studies of statins and CoQ10 have produced mixed results. Some research does show that this dietary supplement can reduce ...

The severe form of dengue fever, also called dengue hemorrhagic fever, can cause serious bleeding, a sudden drop in blood ...

To summarize, in the recent trial, aspirin at 300 mg/day showed no benefit in improving IDFS in patients with high-risk early ...

Xabi Alonso’s team’s dominance has offered a morale boost for the struggling pharma giant, where employees have been ...

Federal projections of longer-term savings from preventive healthcare measures could incentivize lawmakers to enact more such ...

Aspirin is under clinical development by Philip Morris International and currently in Phase II for Myocardial Infarction.

After Clear Channel, which manages many of the advertisements in the area, said a provocative billboard for a Molly Baz ...

Among participants with high-risk nonmetastatic breast cancer, daily aspirin use did not improve the risk for breast cancer ...

High-risk patients are usually prescribed a regimen of daily, low-dose aspirin to prevent preeclampsia. Instead of using risk ...